Clinical Trial Update: Rationale for New Topical Anthroponotic Cutaneous Leishmaniasis (ACL) Treatment in Kabul [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update discusses the rationale for a new topical treatment for anthroponotic cutaneous leishmaniasis in Kabul, spanning Phase 2 and Phase 3, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Snippet

Sponsor: Waisenmedizin e. V. Promoting Access to Essential Medicine | Conditions: Wound Healing | Phase 2, Phase 3 | Status: COMPLETED